Related Articles
Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells
Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts
Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients
Truncated neurokinin‑1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage